R. Costello (Dublin 9, Ireland), D. Stolz (Basel, Switzerland)
Including the ALERT sessions (Abstracts Leading to Evolution in
Respiratory Medicine Trials), these formats showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, session chairs and viewers will take part lively discussions on the presented trials.
Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO)
S. Turner (Aberdeen (Aberdeenshire), United Kingdom), S. Cotton (Aberdeen (Aberdeenshire), United Kingdom), J. Wood (Aberdeen (Aberdeenshire), United Kingdom), V. Bell (Aberdeen (Aberdeenshire), United Kingdom), A. Raja (Aberdeen (Aberdeenshire), United Kingdom), N. Scott (Aberdeen (Aberdeenshire), United Kingdom), S. Fielding (Aberdeen (Aberdeenshire), United Kingdom), G. Maclennan (Aberdeen (Aberdeenshire), United Kingdom), E. Gaillard (Leicester, United Kingdom), M. Pijnenburg (Rotterdam, Netherlands), M. Thomas (Southampton, United Kingdom), D. Price (Aberdeen, United Kingdom)
|    |
Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma
S. Siddiqui (Leicester, United Kingdom), M. Bozik (Pittsburgh, United States of America), D. Archibald (Pittsburgh, United States of America), S. Dworetzky (Pittsburgh, United States of America), J. Mather (Pittsburgh, United States of America), R. Killingsworth (Pittsburgh, United States of America), S. Ochkur (Scottsdale, United States of America), E. Jacobsen (Scottsdale, United States of America), R. Panettieri (New Brunswick, United States of America), C. Prussin (Pittsburgh, United States of America)
| |
Breathing exercises for specialist care asthma patients: a multicentre randomised trial
K. Andreasson (Naestved, Denmark), S. Skou (Slagelse, Denmark), C. Ulrik (Hvidovre, Denmark), H. Madsen (Odense, Denmark), K. Sidenius (Elsinore, Denmark), C. Porsbjerg (Bispebjerg, Denmark), K. Assing (Aalborg, Denmark), J. Bloch-Nielsen (Silkeborg, Denmark), M. Thomas (Southampton, United Kingdom), U. Bodtger (Naestved, Denmark)
| |
Wrap-up by discussant and discussion
C. Porsbjerg (Copenhagen, Denmark)
| |
RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial
J. Naccache (Paris, France), S. Jouneau (Rennes, France), M. Didier (Bobigny, France), R. Borie (Paris, France), M. Cachanado (Paris, France), A. Bourdin (Montpellier, France), M. Reynaud-Gaubert (Marseille, France), P. Bonniaud (Dijon, France), D. Israel-Biet (Paris, France), G. Prevot (Toulouse, France), S. Hirschi (Strasbourg, France), F. Lebargy (Reims, France), S. Marchand-Adam (Tours, France), N. Bautin (Lille, France), J. Traclet (Lyon, France), E. Gomez (Nancy, France), S. Leroy (Nice, France), F. Gagnadoux (Angers, France), F. Rivière (Clamart, France), E. Bergot (Caen, France), A. Gondouin (Besançon, France), E. Blanchard (Bordeaux, France), A. Parrot (Paris, France), F. Blanc (Nantes, France), A. Chabrol (Suresnes, France), S. Dominique (Rouen, France), A. Gibelin (Paris, France), A. Tazi (Paris, France), L. Berard (Paris, France), P. Brillet (Bobigny, France), M. Debray (Paris, France), A. Rousseau (Paris, France), M. Kerjouan (Rennes, France), O. Freynet (Bobgny, France), M. Dombret (Paris, France), A. Gamez (Montpellier, France), A. Nieves (Marseille, France), G. Beltramo (Dijon, France), J. Pastré (Paris, France), A. Le Borgne-Krams (Toulouse, France), T. Dégot (Strasbourg, France), C. Launois (Reims, France), L. Plantier (Tours, France), L. Wémeau-Stervinou (Lille, France), J. Cadranel (Paris, France), C. Chenivesse (Lille, France), D. Valeyre (Bobigny, France), B. Crestani (Paris, France), V. Cottin (Lyon, France), T. Simon (Paris, France), H. Nunes (Bobigny, France), On Behalf Of The Orphalung Network
| |
Results of a phase 2 study of GLPG1205 for idiopathic pulmonary fibrosis (PINTA)
V. Cottin (Lyon, France), C. Seemayer (Mechelen, Belgium), L. Fagard (Mechelen, Belgium), P. Ford (Mechelen, Belgium), T. Van Der Aa (Mechelen, Belgium), A. De Haas-Amatsaleh (Mechelen, Belgium), E. Santermans (Mechelen, Belgium), E. Sondag (Mechelen, Belgium), T. Maher (Los Angeles, United States of America), U. Costabel (Essen, Germany), I. Strambu (Bucharest, Romania)
| |
Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)
T. Ogura (Yokohama, Japan), Y. MORI (Takamatsu, Japan), K. Kataoka (Seto, Japan), O. Nishiyama (Osakasayama, Japan), M. Ando (Nagoya, Japan), S. Arizono (Hamamatsu, Japan), T. Ogawa (Seto, Japan), A. Shiraki (Ogaki, Japan), K. Ichikado (Kumamoto, Japan), H. Ishimoto (Sakamoto, Japan), H. Ito (Kamogawa, Japan), K. Sakamoto (Nagoya, Japan), K. Tomii (Kobe, Japan), H. Tomioka (Kobe, Japan), T. Tsuda (Kitakyusyu, Japan), R. Kozu (Nagasaki, Japan), Y. Kondoh (Seto, Japan)
| |
Wrap-up by discussant and discussion
V. Cottin (Lyon, France)
| |